Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

MicroRNAs associated with the pathogenesis of multiple sclerosis.
Neuroendothelial NMDA receptors as therapeutic targets in experimental autoimmune encephalomyelitis.
MARK2 Rescues Nogo-66-Induced Inhibition of Neurite Outgrowth via Regulating Microtubule-Associated Proteins in Neurons In Vitro.
Differential Expression of Glucocorticoid Receptor Noncoding RNA Repressor Gas5 in Autoimmune and Inflammatory Diseases.
A new role for the P2Y-like GPR17 receptor in the modulation of multipotency of oligodendrocyte precursor cells in vitro.
Antigen dynamics govern the induction of CD4(+) T cell tolerance during autoimmunity.
Eosinophilic gastroenteritis in a woman with multiple sclerosis on dimethyl fumarate.
Current and emerging treatment of multiple sclerosis.
Progressive solitary sclerosis: Gradual motor impairment from a single CNS demyelinating lesion.
[Anesthesia and Multiple Sclerosis: What needs to be considered?].
Safety and efficacy of amiselimod in relapsing multiple sclerosis (MOMENTUM): a randomised, double-blind, placebo-controlled phase 2 trial.
Fully-integrated framework for the segmentation and registration of the spinal cord white and gray matter.
PARP inhibition in leukocytes diminishes inflammation via effects on integrins/cytoskeleton and protects the blood-brain barrier.
CD40-Mediated NF-κB Activation in B Cells Is Increased in Multiple Sclerosis and Modulated by Therapeutics.
CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis.
Evaluation of pulsing magnetic field effects on paresthesia in multiple sclerosis patients, a randomized, double-blind, parallel-group clinical trial.
Linked Patient-Reported Outcomes Data From Patients With Multiple Sclerosis Recruited on an Open Internet Platform to Health Care Claims Databases Identifies a Representative Population for Real-Life Data Analysis in Multiple Sclerosis.
Screening and characterization of molecules that modulate the biological activity of IFNs-I.
Hemoglobins as new players in multiple sclerosis: metabolic and immune aspects.
Multifrequency magnetic resonance elastography of the brain reveals tissue degeneration in neuromyelitis optica spectrum disorder.
No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.
Bedside to bench to bedside research: Estrogen receptor beta ligand as a candidate neuroprotective treatment for multiple sclerosis.
Inadequate outcome measures are the biggest impediment to successful clinical trials in progressive MS - Commentary.
Activated CD4+ and CD8+ T Cell Proportions in Multiple Sclerosis Patients.
Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma.

Pages